Chronic hepatitis and hepatitis C infection
The early observations of Sharmanov et al., in 19824 were the first to suggest an anti-viral action of camel milk when they found that camel's milk was more effective than mare's milk in improving and normalizing the clinical and biochemical status of patients with chronic active hepatitis. Later observations using camel urine therapy in patients with Bilharzial liver disease supported this finding, as significant improvement was noted in the clinical condition of these patients with marked resolution of the ascites and morphological changes of the cirrhotic liver.42 Subsequent studies have shown that camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes and that the incubation of human leucocytes with camel LF followed by their infection with HCV prevented the entry of the virus into the cells. The conclusion was that the direct interaction between the HCV and camel LF led to complete inhibition of virus entry into the cells; in this respect camel lactoferrin proved to be a more potent anti-viral agent than bovine and human lactoferrins.5 Additionally, camel milk administration clears Schistosoma Mansoni from infected mice, thereby indicating a further beneficial anti-parasitic action of camel milk.43
Source:
http://www.sciencedirect.com/science/article/pii/S1658361216000238
